Correlation Engine 2.0
Clear Search sequence regions


  • cancer (6)
  • Cdkn1a (1)
  • cell growth (1)
  • colitis (1)
  • colon cancer (1)
  • human (2)
  • intestine (1)
  • mice (2)
  • mice knockout (1)
  • mrna (1)
  • PUM1 (6)
  • PUMILIO (8)
  • rna (4)
  • sirnas (1)
  • Sizes of these terms reflect their relevance to your search.

    PUMILIO (PUM) proteins belong to the highly conserved PUF family post-transcriptional regulators involved in diverse biological processes. However, their function in carcinogenesis remains under-explored. Here, we report that Pum1 and Pum2 display increased expression in human colorectal cancer (CRC). Intestine-specific knockout of Pum1 and Pum2 in mice significantly inhibits the progression of colitis-associated cancer in the AOM/DSS model. Knockout or knockdown of Pum1 and/or Pum2 in human CRC cells result in a significant decrease in the tumorigenicity and delayed G1/S transition. We identify p21/Cdkn1a as a direct target of PUM1. Abrogation of the PUM1 binding site in the p21 mRNA also results in decreased cancer cell growth and delayed G1/S transition. Furthermore, intravenous injection of nanoparticle-encapsulated anti-Pum1 and Pum2 siRNAs reduces colorectal tumor growth in murine orthotopic colon cancer models. These findings reveal the requirement of PUM proteins for CRC progression and their potential as therapeutic targets. © 2022. The Author(s).

    Citation

    Yuanyuan Gong, Zukai Liu, Yihang Yuan, Zhenzhen Yang, Jiawei Zhang, Qin Lu, Wei Wang, Chao Fang, Haifan Lin, Sanhong Liu. PUMILIO proteins promote colorectal cancer growth via suppressing p21. Nature communications. 2022 Mar 25;13(1):1627

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 35338151

    View Full Text